Please ensure Javascript is enabled for purposes of website accessibility

What's the Strongest Buy: Moderna, Teladoc Health, or Fulgent Genetics?

By Taylor Carmichael - Feb 26, 2021 at 2:00PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

All three of these stocks have had incredible spikes because of COVID-19. One stock, however, is a safer and stronger long-term investment.

Moderna (MRNA -4.97%)Teladoc Health (TDOC -0.52%) and Fulgent Genetics (FLGT -2.66%) have all had incredible runs over the last year. Moderna is up 570%. Teladoc stock has jumped 127%. And Fulgent has run up 500%. What's the strongest stock? Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool contributor Taylor Carmichael discuss the future of these three COVID-19 stocks. This segment was recorded live on Feb 19.

Corinne Cardina: What I think is really a trend with all three of these stocks is what you said about management. All three of the management and leaders of these companies were able to pivot pretty quickly during the pandemic and react and be resilient and even be anti-fragile, improving during these really hard times when so many other companies were not growing and not pivoting as well as them. Would you agree?

Taylor Carmichael: Yeah, I do think that the management, and I'm particularly impressed with all three really: Teladoc and Fulgent and Moderna. I do think they have capable management. I think as investors, and this would be just a heads-up for all these stocks, it may be a good idea to take a little profit off the table as you go. Precisely because COVID-19 is kind of warping their revenues and their earnings, and there has been a big lump. There's a lot of unknowns, I just want to stress that -- there are a lot of unknowns here in these three. Near-term unknowns because we don't know if COVID is going to go away or if it's going to be with us over the next decade, if it's going to be like the flu. It's a question of whether the mutation of COVID. So that's something for investors to keep in the back of your mind. The safest of these three, in my opinion, is Teladoc Health. That is the safest and probably the strongest investment of these three over the next 10 years.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health, Inc. Stock Quote
Teladoc Health, Inc.
$32.74 (-0.52%) $0.17
Moderna, Inc. Stock Quote
Moderna, Inc.
$136.25 (-4.97%) $-7.13
Fulgent Genetics, Inc. Stock Quote
Fulgent Genetics, Inc.
$56.08 (-2.66%) $-1.53

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/22/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.